Transcriptomic clustering of critically ill COVID-19 patients

Abstract

These results reveal different underlying pathogenetic mechanisms and illustrate the potential of transcriptomics to identify patient endotypes in severe COVID-19 with the aim to ultimately personalise their therapies.